Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?
Transfusion Medicine · 2026
DOI: 10.1111/tme.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Medicine, 2026. Verfasst von Niamh O'Flaherty und 6 weiteren Autor:innen. Beteiligte Einrichtung: Irish Blood Transfusion Service, Dublin, Ireland. Hauptthemen laut MEDLINE: Blood Donors, Hepatitis E, Hepatitis E virus, RNA, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Screening blood donations for HEV RNA mitigates the risk of transfusion‐transmitted HEV infection (TT‐HEV), a recognised blood safety issue in Europe. This study reports the findings of government‐funded HEV RNA blood donation screening 2016–2022 and includes an estimate of residual risk.
Method
Donation samples were universally and individually tested for HEV RNA using the Procleix HEV assay. Repeat reactive samples were referred for further molecular (PCR, viral load, genotyping) and serological analyses. A previously described model was used for the estimation of residual risk.
Results
229 HEV RNA positive donations were identified in 980 690 donations. Serological window period donations accounted for 148 (65%) of cases. HEV RNA donation positivity ranged from 1 in 6153 (0.016%) to 1 in 2314 (0.043%). In the absence of screening and with a residual plasma volume of 10 mL, >19% of the Hepatitis E virus positive Red Cell Concentrates ( n = 42/220) could have resulted in transmission. The residual risk, based on a window period of 14 days was estimated at 51 per million donations. At least 15 components with infectious doses of >1 × 10 6 IU were interdicted.
Conclusions
Autochthonous asymptomatic HEV infection continues to occur in Irish donors with relative frequency. As donors with higher viral loads can lead to infectious donations, the value of screening the blood supply for HEV is evident and supported by an absence of reported TT HEV cases. Interventions to control foodborne HEV may reduce the relative benefit of screening in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Irish Blood Transfusion Service, Dublin, Ireland.
- National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
- School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
Zitieren
APA
O'Flaherty, N., Mullarkey, M., Burke, L., Williams, P., Dean, J., Szulc, J., & Waters, A. (2026). Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?. Transfusion Medicine. https://doi.org/10.1111/tme.70047
Vancouver
O'Flaherty N, Mullarkey M, Burke L, Williams P, Dean J, Szulc J, et al. Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?. Transfusion Medicine. 2026. doi:10.1111/tme.70047
BibTeX
@article{OFlaherty2026,
author = {O'Flaherty, Niamh and Mullarkey, Marice and Burke, Lisa and Williams, Pádraig and Dean, Jonathan and Szulc, Jola and Waters, Allison},
title = {Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?},
journal = {Transfusion Medicine},
year = {2026},
doi = {10.1111/tme.70047}
}
EUVIMED